CKD Bio Corp. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 0.00018 million compared to negative sales of KRW 0.00103 million a year ago. Net loss was KRW 4,923.49 million compared to net income of KRW 477.48 million a year ago. Basic loss per share from continuing operations was KRW 897 compared to basic earnings per share from continuing operations of KRW 87 a year ago. Basic loss per share was KRW 897 compared to basic earnings per share of KRW 87 a year ago.
For the six months, negative sales was KRW 0.00031 million compared to KRW 0.00001 million a year ago. Net loss was KRW 6,128.04 million compared to KRW 1,482.87 million a year ago. Basic loss per share from continuing operations was KRW 1,117 compared to KRW 270 a year ago. Basic loss per share was KRW 1,117 compared to KRW 270 a year ago.